IP Library › Granted Patent US 9,408,748
Granted Patent B2
US 9,408,748 · App. 14/953,274 · Granted Aug 9, 2016

Laser apparatus and method for refractive surgery

Inventor: Gregory John Roy Spooner (San Francisco, CA)
A61F9/00827A61F9/00836A61F2009/0087A61F2009/0088A61F2009/00846A61F2009/00865A61F2009/00872A61F2009/00882A61F2009/00887A61F2009/00891A61F2009/00895
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,748
App. No.
14/953,274
Granted
Aug 9, 2016
Kind
B2
Abstract

An ultrashort pulsed laser instrument is used to perform refractive surgery. The invention operates in ablative and incisional modalities. In the ablative mode, spiral ablation disks ( 10 ) consisting of individual laser pulses ( 40 ) are produced at high scanning speeds. Ablation profile ( 11 ) may be produced in cornea ( 22 ) by stacking and arranging multiple ablation disks ( 10 ) to produce a specified shape change. Placement of ablation disks ( 10 ) is assisted by an optical tracking and control system that compensates for eye motion. A preferred embodiment allows for ablative corrections to be performed on non-planar posterior surface ( 112 ) of a laser cut flap affixed to registration platen ( 120 ), thereby avoiding exposing the eye interior to high radiant power. Laser cut and contrast agent dyed fiduciary marks ( 30 ) may serve as reference features for the optical tracking system. Incisional procedures, such as corneal flaps for LASIK, may also be performed.

Claims (14)

1. A method for producing high optical contrast fiduciary marks in corneal tissue comprising the steps of:

a. focusing short or ultrashort laser pulses on a corneal surface;

b. scanning the laser pulses onto the corneal surface in a predetermined pattern to make one or more incisions in the corneal surface, the one or more incisions having a predetermined width and a predetermined depth;

c. applying contrast agent to the corneal surface, wherein the contrast agent binds to the one or more incisions;

d. removing excess contrast agent from the corneal surface, wherein removal of the excess contrast agent localizes a remaining amount of contrast agent in the one or more incisions to create optical contrast between the corneal surface and the one or more incisions, wherein the optical contrast is referenced by an optical tracking device to guide a laser ablation procedure on the corneal tissue.

2. The method of claim 1 , further comprising the step of verifying proper position of a laser on the corneal surface prior to initiating the scanning.

3. The method of claim 2 , wherein an optical means is used to verify the proper position of the laser.

4. The method of claim 1 , wherein a width and a depth of the one or more incisions is minimized to avoid interfering with visual acuity of a patient.

5. The method of claim 4 , wherein the width of the one or more incisions is 1 to 30 microns, wherein the width of the one or more incisions is optimally 5 to 15 microns, and wherein the depth of the one or more incisions is 10 to 100 microns, wherein the depth of the one or more incisions is optimally 20 to 50 microns.

6. The method of claim 1 , wherein the one or more incisions are made in a stromal bed, wherein the stromal bed is exposed by cutting and lifting a corneal flap.

7. The method of claim 1 , wherein the one or more incisions are made in a posterior surface of a corneal flap.

8. The method of claim 1 , wherein the one or more incisions are made on an anterior surface of a cornea.

9. The method of claim 1 , wherein the contrast agent is applied by irrigating or wiping the contrast on the one or more incisions.

10. The method of claim 1 , wherein the contrast agent is selected from the group consisting of biocompatible dyes, ophthalmic fluorescent dyes, biocompatible optical scattering agents, biodegradable agents, and biocompatible pigments.

Continuity (3)
Division 13244446 · Sep 24, 2011
Provisional Application 61386507 · Sep 25, 2010
Related Publication 20160074226A1 · Mar 17, 2016